These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21855725)

  • 1. Shape and configuration of skin lesions: targetoid lesions.
    Wolf R; Lipozencic J
    Clin Dermatol; 2011; 29(5):504-8. PubMed ID: 21855725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In the pursuit of classifying severe cutaneous adverse reactions.
    Wolf R; Wolf D; Davidovici B
    Clin Dermatol; 2007; 25(3):348-9. PubMed ID: 17560313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.
    Assier H; Bastuji-Garin S; Revuz J; Roujeau JC
    Arch Dermatol; 1995 May; 131(5):539-43. PubMed ID: 7741539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal disease series. Number IV. Erythema multiforme.
    Farthing P; Bagan JV; Scully C
    Oral Dis; 2005 Sep; 11(5):261-7. PubMed ID: 16120111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology.
    Niemeijer IC; van Praag MC; van Gemund N
    Arch Gynecol Obstet; 2009 Nov; 280(5):851-4. PubMed ID: 19277691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H; Ohtoshi S; Nakada T; Iijima M
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review.
    Yager JA
    Vet Dermatol; 2014 Oct; 25(5):406-e64. PubMed ID: 24990284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral mucosal diseases: erythema multiforme.
    Scully C; Bagan J
    Br J Oral Maxillofac Surg; 2008 Mar; 46(2):90-5. PubMed ID: 17767983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus.
    Torchia D; Romanelli P; Kerdel FA
    J Am Acad Dermatol; 2012 Sep; 67(3):417-21. PubMed ID: 22101216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythema multiforme. A heterogeneous pathologic phenotype].
    Carrozzo M; Togliatto M; Gandolfo S
    Minerva Stomatol; 1999 May; 48(5):217-26. PubMed ID: 10434539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E
    Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous systemic lupus erythematosus.
    Vassileva S
    Clin Dermatol; 2004; 22(2):129-38. PubMed ID: 15234014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected problems in benign cutaneous pathology.
    Leonard DD; Arrington JH
    Pathol Annu; 1978; 13 Pt 2():351-97. PubMed ID: 219407
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
    Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema multiforme.
    Stampien TM; Schwartz RA
    Am Fam Physician; 1992 Oct; 46(4):1171-6. PubMed ID: 1414882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.